Model‐Informed Dosing of Venetoclax in Healthy Subjects: An Exposure−Response Analysis
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Translational Science"
DOI: 10.1111/cts.12665
Abstract: Venetoclax is an approved drug for the treatment of some hematological malignancies. Venetoclax can cause reduction in B‐lymphocyte counts as an on‐target effect. The purpose of this analysis is to quantify the relationship between venetoclax… read more here.
Keywords: venetoclax healthy; exposure response; venetoclax; dosing venetoclax ... See more keywords